Skip to content

A Clinical Trial To See The Efficacy Of Ayurvedic Regimes In The Treatment Of Dry Eye Disorder [Shushkakshipaka]

A Randomized Control Clinical Trial To Evaluate The Efficacy Of Netra Parisheka And Shadanga Guggulu Vati In The Management Of Shushkakshipaka - Computer And Visual Display Terminal Vision Syndrome [CVDTS]

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039137
Enrollment
120
Registered
2022-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H048- Other disorders of lacrimal system

Interventions

None listed

Sponsors

DR SHAILENDRA SINGH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in this trial through written informed consent 2.Patients between 21 to 60 years of age from either sex 3. Patients presenting with clinical features of Sushkakshipaka, described as per Ayurveda Modern science.

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 21 years and above the age of 60 years, 2.Patients not willing for registration, 3. Patients suffering from symptoms of dry eye to causes other than excess exposure to visual display terminals, 4. Patients suffering from systemic illness, 5. Complicated cases with acute/chronic infective diseases of eye lids,conjunctiva, cornea 7 Sclera.

Design outcomes

Primary

MeasureTime frame
The effect of therapy will be assessed on the basis of subjective parameters such as netrayasa,Avila darshana,Netra raga etc. and objective parameters like visual acuity Schirmer 1 test and Tear film breakup time.Timepoint: The effect of therapy will be assessed at baseline [At 0 day ], at the end of treatment protocol [at the 45th day ] and at the end of follow up protocol [ at the 90th day ]

Secondary

MeasureTime frame
The effect of therapy will be long lasting without any side and toxic effects.Timepoint: At 15th,30th & 45 day during the treatment protocol along with at 60th, 75th & 90th during the follow up protocol.

Countries

India

Contacts

Public ContactDR SHAILENDRA SINGH

Shri Krishna Government Ayurvedic College

drashukataria@gmail.com7015960328

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026